Ainos (STU:FZX) FCF Margin % : 0.00% (As of Jun. 2024)

View and export this data going back to 2006. Start your Free Trial

What is Ainos FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Ainos's Free Cash Flow for the three months ended in Jun. 2024 was €-1.84 Mil. Ainos's Revenue for the three months ended in Jun. 2024 was €0.00 Mil. Therefore, Ainos's FCF Margin % for the quarter that ended in Jun. 2024 was 0.00%.

As of today, Ainos's current FCF Yield % is -150.15%.

The historical rank and industry rank for Ainos's FCF Margin % or its related term are showing as below:

STU:FZX' s FCF Margin % Range Over the Past 10 Years
Min: -8805.08 Med: -1302.56 Max: -104.4
Current: -8805.08

During the past 13 years, the highest FCF Margin % of Ainos was -104.40%. The lowest was -8805.08%. And the median was -1302.56%.

STU:FZX's FCF Margin % is ranked worse than
98.19% of 828 companies
in the Medical Devices & Instruments industry
Industry Median: -6.405 vs STU:FZX: -8805.08

Ainos FCF Margin % Historical Data

The historical data trend for Ainos's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ainos FCF Margin % Chart

Ainos Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-7,545.45

-2,978.57

-233.97

-104.39

-3,919.64

Ainos Quarterly Data
	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24
FCF Margin %	Get a 7-Day Free Trial															-3,914.81	-3,322.73	-6,916.67	-7,257.89	-

Competitive Comparison of Ainos's FCF Margin %

For the Medical Devices subindustry, Ainos's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ainos's FCF Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ainos's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Ainos's FCF Margin % falls into.

Ainos FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Ainos's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-4.39	/	0.112
	=	-3,919.64 %

Ainos's FCF Margin for the quarter that ended in Jun. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Jun. 2024 )	/	Revenue (Q: Jun. 2024 )
	=	-1.84	/	0
	=	%

Ainos FCF Margin % Related Terms

Thank you for viewing the detailed overview of Ainos's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ainos Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ainos Inc (STU:FZX) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

AIMD:USA

Address

8880 Rio San Diego Drive, Suite 800, San Diego, CA, USA, 92108

Website

https://www.ainos.com

Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low dose oral form.

Ainos Headlines

No Headlines